Iain Dukes
InvestorFounderVenture Partner at OrbiMed · Board director at Theseus Pharmaceuticals · Board director at Angiex · Board director at Ikena Oncology, Inc.
Philadelphia, Pennsylvania
Writes $1M – $75M checks · typically $4M
About
Iain Dukes is a Venture Partner at Orbimed and CEO of Viriom Inc, serving on the executive teams or boards of nine companies across the USA, France, and the UK. His career includes roles as Senior Vice President of Business Development & Licensing at Merck, where he managed licensing deals for Merck Research Laboratories, as well as Vice President of External Research and Development at Amgen, President and CEO of Essentialis Therapeutics, and Vice President of Scientific and Technology Licensing at GlaxoSmithKline. He holds a BSc in Pharmacology from the University of Bath, an MSc in Cardiovascular Studies from the University of Leeds, a DPhil in Physiology and Pharmacology from the University of Oxford, and an MA in Jurisprudence and Law from the University of Oxford.
Board director at Theseus Pharmaceuticals
Intro paths
In turn, Iain can intro founders to Theseus Pharmaceuticals's investors below.
Theseus Pharmaceuticals's investors · 4
Co-founders at Theseus Pharmaceuticals
Board director at Angiex
Intro paths
In turn, Iain can intro founders to Angiex's investors below.
Angiex's investors · 3
Co-founders at Angiex
Board director at Ikena Oncology, Inc.
Intro paths
In turn, Iain can intro founders to Ikena Oncology, Inc.'s investors below.
Ikena Oncology, Inc.'s investors · 3
Co-founders at Ikena Oncology, Inc.
Experience
- Viriom IncCEOcurrent2019 — presentSan Diego, CA
- Theseus PharmaceuticalsCEOcurrent2018 — presentCambridge, MA
- ENYO PharmaBoard Membercurrent2018 — presentLyon, France
- KaNDY Therapeutics, Ltd.Chairman of the Boardcurrent2017 — presentStevenage, UK
- Kartos TherapeuticsPresidentcurrent2017 — present
- NeRRE Therapeutics, Ltd.Board Membercurrent2017 — presentStevenage, United Kingdom
- ReViral, Ltd.Board Membercurrent2016 — presentStevenage, United Kingdom
- Iovance Biotherapeutics, Inc.Chairman of the Boardcurrent2016 — presentSan Carlos, CA
- Kyn Therapeutics, Inc.Board Membercurrent2016 — presentBoston, MA
- OrbiMedVenture Partnercurrent2016 — presentNew York, NY
- MerckSVP Licensing & External Science2013 — 2016Upper Gwynedd, Pa
- AmgenVP External R&D2010 — 2013
- Biotech ConsultingPresident2009 — 2010Greater Philadelphia Area
- Essentialis TherapeuticsPresident & CEO2007 — 2009Greater San Diego Area
- GlaxoSmithKlineVP Scientific and Technology Licensing2000 — 2007Research Triangle Park, NC
Education
- University of OxfordMA, Jurisprudence (Law)1986 — 1989
- University of OxfordDPhil, Physiology/Pharmacology1981 — 1983
- University of LeedsMSc, Cardiovascular Studies1980 — 1981
- University of BathBSc, Pharmacology1976 — 1980
Skills & more
+4 more
Business DevelopmentOncologyLife SciencesCommercializationFrom Iain's professional profile.
Deals · 2
Ikena Oncology, Inc.Board seat
via OrbiMed · filed Jul 2025 · $75M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at OrbiMed
Frequently asked questions
- Where does Iain Dukes work?
- Iain Dukes is Venture Partner at OrbiMed and Founder at Theseus Pharmaceuticals and Founder at Angiex and Founder at Ikena Oncology, Inc..
- What check size does Iain Dukes write?
- Iain Dukes typically writes checks of $1M – $75M.
- What companies did Iain Dukes found?
- Iain Dukes founded Angiex, Ikena Oncology, Inc., Theseus Pharmaceuticals.
Founder mafias
University of Oxford mafia282
Also came through, then founded or led a company.
+ 275 more
University of Bath mafia22
Also came through, then founded or led a company.
+ 15 more
University of Leeds mafia22
Also came through, then founded or led a company.
.png)
+ 15 more
OrbiMed mafia6
Also came through, then founded or led a company.
Same school
Also attended University of Oxford950
+ 944 more
Also attended University of Leeds127
+ 121 more
Also attended University of Bath106
+ 100 more
Shared employers
Also worked at ENYO Pharma1
Also worked at Kartos Therapeutics2
Also worked at Iovance Biotherapeutics, Inc.1
Also worked at Merck103
+ 97 more